These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-κB signaling. Heymann MC; Winkler S; Luksch H; Flecks S; Franke M; Ruß S; Ozen S; Yilmaz E; Klein C; Kallinich T; Lindemann D; Brenner S; Ganser G; Roesler J; Rösen-Wolff A; Hofmann SR J Immunol; 2014 May; 192(9):4379-85. PubMed ID: 24706726 [TBL] [Abstract][Full Text] [Related]
23. Identification of a regulatory autophosphorylation site in the serine-threonine kinase RIP2. Dorsch M; Wang A; Cheng H; Lu C; Bielecki A; Charron K; Clauser K; Ren H; Polakiewicz RD; Parsons T; Li P; Ocain T; Xu Y Cell Signal; 2006 Dec; 18(12):2223-9. PubMed ID: 16824733 [TBL] [Abstract][Full Text] [Related]
24. Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity. Lu C; Wang A; Dorsch M; Tian J; Nagashima K; Coyle AJ; Jaffee B; Ocain TD; Xu Y J Biol Chem; 2005 Apr; 280(16):16278-83. PubMed ID: 15691841 [TBL] [Abstract][Full Text] [Related]
25. Receptor interacting protein-2 plays a critical role in human lung epithelial cells survival in response to Fas-induced cell-death. Rahman MA; Sundaram K; Mitra S; Gavrilin MA; Wewers MD PLoS One; 2014; 9(3):e92731. PubMed ID: 24658576 [TBL] [Abstract][Full Text] [Related]
26. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Kobayashi K; Inohara N; Hernandez LD; Galán JE; Núñez G; Janeway CA; Medzhitov R; Flavell RA Nature; 2002 Mar; 416(6877):194-9. PubMed ID: 11894098 [TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of receptor-interacting protein 2 as a TNFR-associated factor 3 binding partner. Cai X; Du J; Liu Y; Xia W; Liu J; Zou M; Wang Y; Wang M; Su H; Xu D Gene; 2013 Apr; 517(2):205-11. PubMed ID: 23333941 [TBL] [Abstract][Full Text] [Related]
28. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease. Wang X; Wang H; Figueroa BE; Zhang WH; Huo C; Guan Y; Zhang Y; Bruey JM; Reed JC; Friedlander RM J Neurosci; 2005 Dec; 25(50):11645-54. PubMed ID: 16354923 [TBL] [Abstract][Full Text] [Related]
30. Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. Sun X; Yin J; Starovasnik MA; Fairbrother WJ; Dixit VM J Biol Chem; 2002 Mar; 277(11):9505-11. PubMed ID: 11734559 [TBL] [Abstract][Full Text] [Related]
31. Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Kim JW; Choi EJ; Joe CO Oncogene; 2000 Sep; 19(39):4491-9. PubMed ID: 11002422 [TBL] [Abstract][Full Text] [Related]
32. Prokaryotic expression, purification and functional characterization of recombinant human RIP2. Cai X; Wang M; Kong H; Liu J; Liu Y; Xia W; Zou M; Wang J; Su H; Xu D Mol Biol Rep; 2013 Jan; 40(1):59-65. PubMed ID: 23135732 [TBL] [Abstract][Full Text] [Related]
33. CARD tricks: controlling the interactions of CARD6 with RICK and microtubules. Dufner A; Mak TW Cell Cycle; 2006 Apr; 5(8):797-800. PubMed ID: 16582588 [TBL] [Abstract][Full Text] [Related]
34. Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Druilhe A; Srinivasula SM; Razmara M; Ahmad M; Alnemri ES Cell Death Differ; 2001 Jun; 8(6):649-57. PubMed ID: 11536016 [TBL] [Abstract][Full Text] [Related]
35. Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity. Charnley AK; Convery MA; Lakdawala Shah A; Jones E; Hardwicke P; Bridges A; Ouellette M; Totoritis R; Schwartz B; King BW; Wisnoski DD; Kang J; Eidam PM; Votta BJ; Gough PJ; Marquis RW; Bertin J; Casillas L Bioorg Med Chem; 2015 Nov; 23(21):7000-6. PubMed ID: 26455654 [TBL] [Abstract][Full Text] [Related]
36. Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell death. Wang X; Narayanan M; Bruey JM; Rigamonti D; Cattaneo E; Reed JC; Friedlander RM Biochim Biophys Acta; 2006 Aug; 1762(8):742-54. PubMed ID: 16920334 [TBL] [Abstract][Full Text] [Related]
37. Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation. Pellegrini E; Signor L; Singh S; Boeri Erba E; Cusack S PLoS One; 2017; 12(5):e0177161. PubMed ID: 28545134 [TBL] [Abstract][Full Text] [Related]
38. RIP2 enhances cell survival by activation of NF-ĸB in triple negative breast cancer cells. Jaafar R; Mnich K; Dolan S; Hillis J; Almanza A; Logue SE; Samali A; Gorman AM Biochem Biophys Res Commun; 2018 Feb; 497(1):115-121. PubMed ID: 29421659 [TBL] [Abstract][Full Text] [Related]
39. Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Yoo NJ; Park WS; Kim SY; Reed JC; Son SG; Lee JY; Lee SH Biochem Biophys Res Commun; 2002 Dec; 299(4):652-8. PubMed ID: 12459189 [TBL] [Abstract][Full Text] [Related]
40. RIP5 is a RIP-homologous inducer of cell death. Zha J; Zhou Q; Xu LG; Chen D; Li L; Zhai Z; Shu HB Biochem Biophys Res Commun; 2004 Jun; 319(2):298-303. PubMed ID: 15178406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]